Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China

Published:2022-12 Issue: Volume:537 Page:118-126
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Gao Juan-Juan,Wang Ya-Wen,Li Yang,Wang Zhong-Lin,Feng Ai,Li Na,Hui Ling-Yun

Funder

Xi’an Jiaotong University

Shanxi Provincial Key Research and Development Project

Shaanxi Province Key Research and Development Projects

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

3. Cancer treatment and survivorship statistics, 2019;Miller;CA Cancer J. Clin.,2019

4. Colorectal cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

5. Prescreening with FOBT improves yield and is cost-effective in colorectal screening in the elderly;Singhal;ISRN Gastroenterol.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer;BMC Cancer;2024-07-27

2. Screening value of methylated Septin9 and lymphocyte-to-monocyte ratio in colorectal cancer;Medicine;2024-05-31

3. CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment;Biotechnology and Bioengineering;2023-11-21

4. Diagnostic value of new combination of methylated Septin9 with LMR in adenomatous polyps and stage I to IV colorectal cancer;2023-04-19

5. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor;Cancer Treatment and Research Communications;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3